Q&A

Jack Gilbert is teasing out how microbes transform their home environments, from the comfort of his own.

Robert Schultz hopes to use technology to change how autism is studied, diagnosed and treated.

Researchers use a variety of measures and definitions to characterize autistic children who speak few or no words.

Developmental pediatrician Watfa Al-Mamari is building an autism program in Oman from the ground up.

An award-winning photography series offers a close look at one autistic person coming of age in New York City.

After a decade of working with the Phelan-McDermid Syndrome Foundation, Geraldine Bliss has co-founded a new organization to develop therapies for the condition.

Khara Ramos explains how the Brain Initiative incorporates the emerging field of ‘neuroethics’ into the research it funds.

Molecular biologist Jonathan Mill is probing gene expression’s role in autism in uncharted territory — the fetal human brain.

Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.

Annie Ciernia describes the greenhouse origins of her scientific career and why a unicorn makes a good lab mascot.